AU2002231659A1 - Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof - Google Patents
Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereofInfo
- Publication number
- AU2002231659A1 AU2002231659A1 AU2002231659A AU2002231659A AU2002231659A1 AU 2002231659 A1 AU2002231659 A1 AU 2002231659A1 AU 2002231659 A AU2002231659 A AU 2002231659A AU 2002231659 A AU2002231659 A AU 2002231659A AU 2002231659 A1 AU2002231659 A1 AU 2002231659A1
- Authority
- AU
- Australia
- Prior art keywords
- triscarboxymethyl
- tetraazacyclododecane
- dihydroxypropyl
- hydroxymethyl
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JZNZSKXIEDHOBD-UHFFFAOYSA-N 2-[4,10-bis(carboxymethyl)-7-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound OCC(O)C(CO)N1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 JZNZSKXIEDHOBD-UHFFFAOYSA-N 0.000 title 1
- 150000002641 lithium Chemical class 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10064467A DE10064467C2 (en) | 2000-12-15 | 2000-12-15 | Lithium complexes of N- (1-hydroxymethyl-2,3-dihydroxypropyl) -1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their preparation and use |
DE10064467,8 | 2000-12-15 | ||
PCT/EP2001/014283 WO2002048119A2 (en) | 2000-12-15 | 2001-12-05 | Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002231659A1 true AU2002231659A1 (en) | 2002-08-29 |
AU2002231659B2 AU2002231659B2 (en) | 2007-07-05 |
Family
ID=7668584
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002231659A Expired AU2002231659B2 (en) | 2000-12-15 | 2001-12-05 | Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
AU3165902A Pending AU3165902A (en) | 2000-12-15 | 2001-12-05 | Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU3165902A Pending AU3165902A (en) | 2000-12-15 | 2001-12-05 | Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
Country Status (35)
Country | Link |
---|---|
US (1) | US6894151B2 (en) |
EP (1) | EP1343770B1 (en) |
JP (1) | JP4399163B2 (en) |
KR (1) | KR100869627B1 (en) |
CN (1) | CN1229357C (en) |
AR (1) | AR035609A1 (en) |
AT (1) | ATE430737T1 (en) |
AU (2) | AU2002231659B2 (en) |
BG (1) | BG66117B1 (en) |
BR (1) | BR0116219A (en) |
CA (1) | CA2431976C (en) |
CY (1) | CY1109280T1 (en) |
CZ (1) | CZ304573B6 (en) |
DE (2) | DE10064467C2 (en) |
DK (1) | DK1343770T3 (en) |
EC (1) | ECSP034676A (en) |
EE (1) | EE05245B1 (en) |
ES (1) | ES2325982T3 (en) |
HK (1) | HK1064098A1 (en) |
HR (1) | HRP20030576B1 (en) |
HU (1) | HU229657B1 (en) |
IL (1) | IL156432A0 (en) |
ME (1) | ME00157B (en) |
MX (1) | MXPA03005240A (en) |
NO (1) | NO324864B1 (en) |
NZ (1) | NZ526478A (en) |
PL (1) | PL204181B1 (en) |
PT (1) | PT1343770E (en) |
RS (1) | RS51862B (en) |
RU (1) | RU2003120513A (en) |
SK (1) | SK287424B6 (en) |
TW (1) | TWI302531B (en) |
UY (1) | UY27056A1 (en) |
WO (1) | WO2002048119A2 (en) |
ZA (1) | ZA200305421B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112840A2 (en) * | 2003-06-25 | 2004-12-29 | Guerbet | Peptide conjugate for magnetic resonance imaging |
FR2867473B1 (en) | 2004-03-12 | 2006-06-23 | Guerbet Sa | PORPHYRINE COMPOUND AND HIGH FIELD USE IN MRI |
EP1765812B1 (en) * | 2004-07-02 | 2009-04-29 | Bracco Imaging S.p.A | Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
KR20080108989A (en) * | 2006-03-14 | 2008-12-16 | 말린크로트, 인코포레이티드 | Metal complexes of tetraazamacrocycle derivatives |
US7777029B2 (en) * | 2006-05-02 | 2010-08-17 | San Diego State University (Sdsu) Foundation | Bifunctional chelators for sequestering lanthanides |
DE102009057274B4 (en) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol preparation using trioxobicyclo-octane |
WO2011054480A1 (en) | 2009-11-09 | 2011-05-12 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol production by means of a ceramic membrane |
DE102009053252B3 (en) * | 2009-11-09 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Making gadobutrol, to diagnose stroke, comprises e.g. reacting N-(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-tetraaza-cyclododecane lithium chloride or bromide complex with haloacetic acid and lithium hydroxide or N-methyl imidazole |
DE102010013833A1 (en) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Producing gadolinium complex of N-(hydroxymethyl-dihydroxypropyl)-triscarboxymethyl-tetraazacyclododecane useful as magnetic resonance imaging contrast agent, comprises e.g. reacting cyclic compound with dimethylformamide dimethylacetal |
DE102010023105A1 (en) | 2010-06-04 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol preparation in a one-pot process using DMF-acetal and N-methylimidazole |
RS60001B1 (en) | 2011-04-21 | 2020-04-30 | Bayer Ip Gmbh | Preparation of high-purity gadobutrol |
CN106543094A (en) * | 2016-11-04 | 2017-03-29 | 嘉实(湖南)医药科技有限公司 | The preparation method of high-purity gadobutrol |
KR101971435B1 (en) * | 2017-08-29 | 2019-04-24 | 주식회사 엔지켐생명과학 | Gadobutrol intermediate and method for preparing gadobutrol using the same |
KR102033964B1 (en) * | 2018-01-19 | 2019-10-18 | 주식회사 엔지켐생명과학 | Gadoteridol intermediate and method for preparing gadoteridol using the same |
CN111039885B (en) * | 2019-12-06 | 2021-03-05 | 广州康瑞泰药业有限公司 | Method for preparing high-purity combretastatin |
KR20210112910A (en) * | 2020-03-06 | 2021-09-15 | 주식회사 엔지켐생명과학 | Method for manufacturing calcobutrol to gadovist excipient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4009119A1 (en) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
DE19724186C2 (en) | 1997-06-02 | 2002-07-18 | Schering Ag | Process for the mono- and 1,7-bis-N-ß-hydroxyalkylation of cycles and the corresponding N-ß-hydroxyalkyl-1,4,7,10-tetraazacyclododecane-Li salt complexes |
-
2000
- 2000-12-15 DE DE10064467A patent/DE10064467C2/en not_active Expired - Lifetime
-
2001
- 2001-11-07 TW TW090127671A patent/TWI302531B/en not_active IP Right Cessation
- 2001-12-05 SK SK729-2003A patent/SK287424B6/en not_active IP Right Cessation
- 2001-12-05 ES ES01991788T patent/ES2325982T3/en not_active Expired - Lifetime
- 2001-12-05 DE DE50114889T patent/DE50114889D1/en not_active Expired - Lifetime
- 2001-12-05 JP JP2002549650A patent/JP4399163B2/en not_active Expired - Lifetime
- 2001-12-05 DK DK01991788T patent/DK1343770T3/en active
- 2001-12-05 ME MEP-2008-157A patent/ME00157B/en unknown
- 2001-12-05 PT PT01991788T patent/PT1343770E/en unknown
- 2001-12-05 AU AU2002231659A patent/AU2002231659B2/en not_active Expired
- 2001-12-05 PL PL366141A patent/PL204181B1/en unknown
- 2001-12-05 AU AU3165902A patent/AU3165902A/en active Pending
- 2001-12-05 EE EEP200300282A patent/EE05245B1/en unknown
- 2001-12-05 CA CA2431976A patent/CA2431976C/en not_active Expired - Lifetime
- 2001-12-05 CN CNB018206808A patent/CN1229357C/en not_active Expired - Lifetime
- 2001-12-05 AT AT01991788T patent/ATE430737T1/en active
- 2001-12-05 BR BRPI0116219-5A patent/BR0116219A/en not_active IP Right Cessation
- 2001-12-05 IL IL15643201A patent/IL156432A0/en active IP Right Grant
- 2001-12-05 RU RU2003120513/04A patent/RU2003120513A/en not_active Application Discontinuation
- 2001-12-05 RS YU48103A patent/RS51862B/en unknown
- 2001-12-05 EP EP01991788A patent/EP1343770B1/en not_active Expired - Lifetime
- 2001-12-05 HU HU0302563A patent/HU229657B1/en unknown
- 2001-12-05 CZ CZ2003-1641A patent/CZ304573B6/en not_active IP Right Cessation
- 2001-12-05 MX MXPA03005240A patent/MXPA03005240A/en active IP Right Grant
- 2001-12-05 KR KR1020037008035A patent/KR100869627B1/en active IP Right Grant
- 2001-12-05 UY UY27056A patent/UY27056A1/en not_active Application Discontinuation
- 2001-12-05 WO PCT/EP2001/014283 patent/WO2002048119A2/en active IP Right Grant
- 2001-12-05 NZ NZ526478A patent/NZ526478A/en not_active IP Right Cessation
- 2001-12-13 US US10/013,840 patent/US6894151B2/en not_active Expired - Lifetime
- 2001-12-14 AR ARP010105797A patent/AR035609A1/en unknown
-
2003
- 2003-06-04 NO NO20032523A patent/NO324864B1/en not_active IP Right Cessation
- 2003-06-12 BG BG107901A patent/BG66117B1/en unknown
- 2003-06-26 EC EC2003004676A patent/ECSP034676A/en unknown
- 2003-07-14 ZA ZA200305421A patent/ZA200305421B/en unknown
- 2003-07-15 HR HR20030576A patent/HRP20030576B1/en not_active IP Right Cessation
-
2004
- 2004-09-10 HK HK04106890A patent/HK1064098A1/en not_active IP Right Cessation
-
2009
- 2009-08-06 CY CY20091100837T patent/CY1109280T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002231659A1 (en) | Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof | |
AU3165902A (en) | Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof | |
AU2465401A (en) | Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses | |
AU2002310256A1 (en) | Ppp2cs as modifiers of the p53 pathway and methods of use | |
AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
AU2002226486A1 (en) | Novel c-glycoside derivatives and use thereof | |
AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
AU2002226487A1 (en) | Novel c-glycoside derivatives and use thereof | |
AU2002223647A1 (en) | Aryl-substituted indirubin derivatives, the production thereof and use of the same | |
AU2001281850A1 (en) | Use of inulin and inulin derivatives | |
AU4923200A (en) | Isothiazolecarboxamides and their use as microbicides | |
AU2002214948A1 (en) | Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents | |
AU2002308891A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
PL367676A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
AU2001284068A1 (en) | Monitoring of patient's electrical characteristics | |
AU2001235437A1 (en) | Isothiazolecarboxylic acid derivatives and their use as microbicides | |
AU5464901A (en) | Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides | |
AU2002308889A1 (en) | Novel heterocyclic compound and medicinal use thereof | |
HUP0100318A3 (en) | Salicyli denaminoalcohol derivatives, their chiral copper complexes, their preparations and use of the latter | |
AU2001225523A1 (en) | Novel arylpropionaldehyde derivatives and production and use of the same | |
AU2001268903A1 (en) | Hexaglucal compound and the use and the methods of preparing them | |
AU2001282268A1 (en) | Phenantridine derivatives and their use as anti-telomerase agent | |
AU2001255708A1 (en) | Synthesis and use of thienotriazolodiazepines | |
AU2003215688A1 (en) | Derivatives of 3,3',5,5'-tetraalkylbenzidine bis {mono-carboxylatobenzenepolycarboxylic} and applications thereof | |
AU2002316994A1 (en) | Gdp-mannose-3',5'-epimerase and methods of use thereof |